register

News - MedTech & Diagnostics

Australia’s first robotic system delivers complex surgery with just one tiny cut

Health Industry Hub | August 13, 2025 |

A Melbourne hospital has become the first in Australia to adopt cutting-edge robotic technology capable of performing complex surgery through just one tiny incision.

Epworth Richmond, a pioneer in robotic surgery since performing the nation’s first procedure in 2003, is again setting the pace with the introduction of the da Vinci Single Port (SP) surgical system, distributed locally by Device Technologies.

Unlike traditional robotic systems, which require four robotic arms entering the body through separate 8mm incisions, the da Vinci SP uses a single 25mm entry point. The telescope and instruments are inserted straight into the body, before unfolding “like snakes” once inside. This design allows the separation needed between the surgical instruments and 3D telescope, enabling a wide range of robotic procedures, including urology, gynaecology, thoracic, cardiac, colorectal, and general surgery.

“Patients may be left with just one small scar, which can often be hidden entirely – through the bellybutton for example – and may experience a faster recovery following surgery,” said Epworth urologist Professor Declan Murphy.

Professor Murphy noted that the single port system could also expand access to robotic surgery for patients whose conditions require operating in confined spaces, such as head and neck cancer surgery via the throat.

“We still see a significant role for multi-port robotic surgery, which continues to allow for precise surgery within the body, but this new single port system offers our surgeons more options to deliver the best outcomes for our patients,” he explained.

Colorectal surgeon, Associate Professor Satish Warrier, welcomed the addition of the single port robot to Epworth Richmond’s fleet of robotic systems.

“It won’t replace other robotic-assisted surgery for all cases, but it plays a role for select patients requiring colon and rectal procedures, which is significant for us as surgeons, but also for our patients,” he said. “With robotic systems, the surgeon is still in control. The robot is an extension of our hand as we are controlling the equipment.”

The technology also marks a significant advance in minimally invasive gynaecologic surgery, offering the ability to treat complex conditions such as extensive endometriosis or large fibroids through a single site. Historically, such cases may have required larger incisions or multiple ports, increasing recovery times and surgical risk.

With Australian approval now granted for the da Vinci SP in gynaecologic procedures, the system opens new opportunities to deliver minimally invasive options to women, particularly in cases that were previously more challenging to manage laparoscopically.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.

The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.


News - MedTech & Diagnostics

Hearts4heart takes aim at private system leaving patients to pay the price

Hearts4heart takes aim at health insurers leaving patients to pay the price

Health Industry Hub | September 4, 2026 |

Persistent advocacy by patient groups has prompted the Medical Services Advisory Committee (MSAC) to review the funding gaps for pulsed […]

More


News - MedTech & Diagnostics

Queensland first: Private hospital deploys Abbott's PFA in atrial fibrillation

Queensland first: Private hospitals deploy Abbott’s PFA in atrial fibrillation

Health Industry Hub | September 4, 2026 |

More Australians living with atrial fibrillation (AF) are gaining access to one of the latest advances in heart-rhythm treatment, with […]

More


News - Pharmaceuticals

Five years of HTA reform talk, Now comes the $47 billion question

Five years of HTA reform talk, now comes the $47 billion question

Health Industry Hub | September 4, 2026 |

Medicines Australia has put a $47 billion price tag on what it says Australia must invest to improve equitable access […]

More


News - Pharmaceuticals

New MFN deals raise the stakes for Australia’s delayed HTA reform

New MFN deals raise the stakes for Australia’s delayed HTA reform

Health Industry Hub | September 2, 2026 |

Four months after the US Trump administration concluded what was expected to be the final tranche of drug-pricing agreements with […]

More


This content is copyright protected. Please subscribe to gain access.